Middle-Aged Adults Taking GLP-1s Could Cut Medical Costs
A fresh health-economics study links the use of GLP-1 obesity drugs to sizable lifetime medical cost reductions for 4...
Index level declines can reflect profit-taking, macro shocks, or sector rotations. This intro covers common indicators to read with context.
23,215 articlesA fresh health-economics study links the use of GLP-1 obesity drugs to sizable lifetime medical cost reductions for 4...
As investors eye helen troy (hele) 2027, the Q1 earnings call could reveal how branded consumer products, e-commerce ...
A fresh take on dine brands (din) 2025, focusing on Q4 signals, brand momentum, and how investors can position themse...
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
The SPDR Russell 1000 Yield Focus ETF nears a $125 price point, anchored by Johnson & Johnson and other blue-chip div...
A Federal Reserve Bank of New York study finds that remote work, not automation, is a key driver of rising unemployme...
When celebrities step into the limelight together, more than headlines shift. This piece breaks down the money mindse...
Micron looks cheaper than its earnings prospects suggest, but a closer look reveals cyclicality, demand swings, and r...
The Supreme Court voided tariffs tied to IEEPA, triggering lawsuits and a complex path for refunds. Courts and agenci...
As AI infrastructure expands, CoreWeave sits at a pivotal point. This guide identifies three key risks investors shou...
As Axogen prepares to report its Q4 2025 results, investors want clarity on growth, margins, and guidance. This artic...
Duolingo built a global audience by offering free lessons and charging a devoted subset of users. As growth slows, in...